Dr Laura Ajram

Partnership Lead

Laura is responsible for setting up and delivering a portfolio of high-impact Syndicates with a focus on neuroscience and mental health.

Working with an extensive, global network of key opinion leaders and stakeholders across industry, the NHS, academia and the charity sector, Laura has a track record of creating impactful collaborations and convening expert groups to address key challenge areas in neuroscience medicines discovery.

Laura is a translational neuroscientist, with a BSc (Hons) in Pharmacology from Kings College London and PhD in Neuropharmacology jointly awarded from the Institute of Psychiatry, Psychology and Neuroscience and Eli Lilly & Co. With 8+ years of experience in academic, industry and clinical research settings, Laura is adept at facilitating industry-academic collaborations at all stages of the translational pipeline.

In 2021 Laura was awarded the ELRIG Early Career Impact Award for making a ‘significant impact in the drug discovery community’.  Alongside her role at MDC, Laura is an active member of the British Pharmacological Society where she recently completed a 3-year term as Trustee (non-exec director) of the Society.